Antibiotice Statistics

Total Valuation

Antibiotice has a market cap or net worth of RON 1.71 billion. The enterprise value is 1.80 billion.

Market Cap	1.71B
Enterprise Value	1.80B

Important Dates

The next estimated earnings date is Monday, February 24, 2025.

Earnings Date	Feb 24, 2025
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Antibiotice has 671.34 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	671.34M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.14%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.15%
Float	117.94M

Valuation Ratios

The trailing PE ratio is 18.48.

PE Ratio	18.48
Forward PE	n/a
PS Ratio	2.59
PB Ratio	1.94
P/TBV Ratio	1.98
P/FCF Ratio	38.55
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.73, with an EV/FCF ratio of 40.65.

EV / Earnings	19.48
EV / Sales	2.73
EV / EBITDA	12.73
EV / EBIT	17.83
EV / FCF	40.65

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.14.

Current Ratio	2.25
Quick Ratio	1.39
Debt / Equity	0.14
Debt / EBITDA	0.86
Debt / FCF	2.75
Interest Coverage	23.10

Financial Efficiency

Return on equity (ROE) is 11.49% and return on invested capital (ROIC) is 6.98%.

Return on Equity (ROE)	11.49%
Return on Assets (ROA)	5.70%
Return on Capital (ROIC)	6.98%
Revenue Per Employee	486,606
Profits Per Employee	68,263
Employee Count	1,352
Asset Turnover	0.60
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+76.60%
50-Day Moving Average	2.93
200-Day Moving Average	2.65
Relative Strength Index (RSI)	35.71
Average Volume (20 Days)	506,109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Antibiotice had revenue of RON 657.89 million and earned 92.29 million in profits. Earnings per share was 0.14.

Revenue	657.89M
Gross Profit	415.60M
Operating Income	100.85M
Pretax Income	95.03M
Net Income	92.29M
EBITDA	141.29M
EBIT	100.85M
Earnings Per Share (EPS)	0.14

Full Income Statement

Balance Sheet

The company has 28.91 million in cash and 121.71 million in debt, giving a net cash position of -92.81 million or -0.14 per share.

Cash & Cash Equivalents	28.91M
Total Debt	121.71M
Net Cash	-92.81M
Net Cash Per Share	-0.14
Equity (Book Value)	879.23M
Book Value Per Share	1.31
Working Capital	256.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 140.57 million and capital expenditures -96.34 million, giving a free cash flow of 44.23 million.

Operating Cash Flow	140.57M
Capital Expenditures	-96.34M
Free Cash Flow	44.23M
FCF Per Share	0.07

Full Cash Flow Statement

Margins

Gross margin is 63.17%, with operating and profit margins of 15.33% and 14.03%.

Gross Margin	63.17%
Operating Margin	15.33%
Pretax Margin	14.44%
Profit Margin	14.03%
EBITDA Margin	21.48%
EBIT Margin	15.33%
FCF Margin	6.72%

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 3.26%.

Dividend Per Share	0.08
Dividend Yield	3.26%
Dividend Growth (YoY)	946.97%
Years of Dividend Growth	1
Payout Ratio	35.96%
Buyback Yield	-0.03%
Shareholder Yield	3.23%
Earnings Yield	5.41%
FCF Yield	2.59%

Dividend Details

Stock Splits

The last stock split was on May 13, 2013. It was a forward split with a ratio of 1.1819213313.

Last Split Date	May 13, 2013
Split Type	Forward
Split Ratio	1.1819213313

Scores

Antibiotice has an Altman Z-Score of 4.01.

Altman Z-Score	4.01
Piotroski F-Score	n/a